Clinical trial
Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver…
NCT00383864 · Hospital Clinic of Barcelona, Other · Completed
Key facts
| NCT number | NCT00383864 |
|---|---|
| Title | Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation. |
| Official title | Randomized Study on the Efficacy and Safety of Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | Pegylated interferon and ribavirin |
| Enrollment | 55 |
| Start date | Jul 1, 2001 |
| Completion | Mar 1, 2006 |
| First posted | Oct 4, 2006 |
| Last update posted | Oct 6, 2006 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: